What are the diagnostic tests for primary hyperparathyroidism (PHPT)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnostic Tests for Primary Hyperparathyroidism

The diagnosis of primary hyperparathyroidism (PHPT) requires simultaneous measurement of serum calcium and intact parathyroid hormone (iPTH), which will show hypercalcemia with an elevated or inappropriately normal PTH level. 1, 2

Initial Diagnostic Tests

  • Serum calcium and iPTH: These should be measured simultaneously as the cornerstone of diagnosis 1, 2

    • Hypercalcemia with elevated or inappropriately normal PTH is diagnostic of PHPT 2
    • Total calcium should be corrected for albumin if albumin is abnormal 1
  • 25-OH Vitamin D: Should be measured to exclude vitamin D deficiency as a secondary cause of elevated PTH 2, 1

    • Vitamin D deficiency can cause secondary hyperparathyroidism and complicate interpretation of PTH levels 2
  • Serum phosphate: Typically low in PHPT due to the phosphaturic effect of PTH 1

  • Serum chloride: Can help in differential diagnosis 3

Additional Laboratory Tests

  • Calcium-to-creatinine clearance ratio: Helps differentiate PHPT from familial hypocalciuric hypercalcemia 3

  • 24-hour urinary calcium: To assess for hypercalciuria, which may influence surgical decisions 2

  • Renal function tests: GFR < 60 mL/min/1.73 m² is an indication for surgery in PHPT 2

Preanalytical Considerations for PTH Measurement

  • Sample type: PTH is more stable in EDTA plasma than in serum 2

    • The IFCC working group recommends measurement of PTH in EDTA plasma 2
  • Timing: PTH has a circadian rhythm; consistent timing of sample collection is important 2

  • Storage conditions: PTH is more stable at 4°C than at room temperature 2

Imaging Studies (After Biochemical Diagnosis)

  • Ultrasound of the neck: First-line localization study for parathyroid adenomas 2, 1

  • Dual-phase 99mTc-sestamibi scintigraphy with SPECT/CT: Highly sensitive when combined with ultrasound 2, 1

    • The combination of these two tests provides the highest sensitivity for localization 2, 1
  • MRI or CT scan: Consider if initial imaging is negative or for ectopic parathyroid tissue 2, 1

Special Considerations

  • PTH assay generation: Both second- and third-generation PTH assays have similar diagnostic sensitivity for PHPT 2

    • Use assay-specific reference values as recommended by international workshops 2
  • Biotin supplements: Can interfere with PTH assays and lead to falsely low or high results 2

  • Factors affecting PTH levels: Race, age, BMI, and vitamin D status all influence PTH concentration 2

Atypical Presentations

  • Normocalcemic PHPT: Normal calcium with elevated PTH (21% of cases) 4

  • Normohormonal PHPT: Elevated calcium with normal PTH (6% of cases) 4

  • Both normal calcium and PTH: Rare presentation (3% of cases) but still consistent with PHPT 4

Common Pitfalls to Avoid

  • Not assessing vitamin D status: Can lead to misinterpretation of elevated PTH 1

  • Using different PTH assays interchangeably: Can affect clinical decisions due to varying sensitivity to PTH fragments 1, 2

  • Relying on imaging for diagnosis: Imaging should only be used for localization after biochemical diagnosis is established, not for diagnosis 2

  • Missing ectopic parathyroid tissue: Approximately 5% of patients with persistent hyperparathyroidism have ectopically located adenomas 5

By following this diagnostic algorithm, clinicians can accurately diagnose primary hyperparathyroidism and distinguish it from other causes of hypercalcemia or elevated PTH.

References

Guideline

Hyperparathyroidism Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Hyperparathyroidism: primary or secondary disease?

Reumatologia clinica, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.